These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. ["You don't need to look in the bag". Social Welfare Board will close the debate on pharmaceutical drug dosages]. Norling H Vardfacket; 1997 Mar; 21(3):4-6. PubMed ID: 9456868 [No Abstract] [Full Text] [Related]
3. [Some aspects on drug safety control]. Pekkarienen A Nord Med; 1967 Nov; 78(47):1539-42. PubMed ID: 6075273 [No Abstract] [Full Text] [Related]
4. [Prescribed drug benefits. Replies]. Sven Farm Tidskr; 1966 Dec; 70(34):815-7. PubMed ID: 5981162 [No Abstract] [Full Text] [Related]
5. [Problems of drug safety]. Liljestrand A Nord Med; 1967 Nov; 78(47):1535-9. PubMed ID: 6075272 [No Abstract] [Full Text] [Related]
6. [Prescribed drug benefits. Remarks from Central Organizations]. Sven Farm Tidskr; 1966 Dec; 70(35):862-4. PubMed ID: 5975562 [No Abstract] [Full Text] [Related]
7. Reimbursing side effects of pharmaceutical drugs--a Scandinavian speciality. Perman E J Insur Med; 1997; 29(1):36-8. PubMed ID: 10173025 [TBL] [Abstract][Full Text] [Related]
8. Implementing accountability for reasonableness--the case of pharmaceutical reimbursement in Sweden. Jansson S Health Econ Policy Law; 2007 Apr; 2(Pt 2):153-71. PubMed ID: 18634660 [TBL] [Abstract][Full Text] [Related]
9. [Drug consumption among drivers suspected for driving under the influence of alcohol. Medical and criminological aspects]. Solarz A Lakartidningen; 1980 Aug; 77(32-33):2706-11. PubMed ID: 7453291 [No Abstract] [Full Text] [Related]
10. Pharmaceutical management through environmental product labeling in Sweden. Wennmalm A; Gunnarsson B Environ Int; 2009 Jul; 35(5):775-7. PubMed ID: 19193440 [TBL] [Abstract][Full Text] [Related]
11. [The Medical Products Agency suggests improved drug safety follow-ups. New grasps of better knowledge and adverse effects reporting]. Sjölin-Forsberg G; Lindeskog B; Lundqvist KM; Feltelius N; Alvan G Lakartidningen; 2007 Apr 18-24; 104(16):1226-9. PubMed ID: 17536352 [No Abstract] [Full Text] [Related]
12. [Swedish pharmaceutical insurance--experiences during 5 years]. Boström H Nord Med; 1984; 99(11):276-8. PubMed ID: 6514555 [No Abstract] [Full Text] [Related]
13. [Mercury-containing drugs. Investigation by the State Pharmaceutical Laboratory of possible harmful effects from mercury-containing drugs]. Rosén A Lakartidningen; 1966 Nov; 63():Suppl 2:51-3. PubMed ID: 5979928 [No Abstract] [Full Text] [Related]
15. [1967 prices of drugs]. Sven Farm Tidskr; 1966 Nov; 70(33):794-801. PubMed ID: 5980006 [No Abstract] [Full Text] [Related]
16. [The basis of drug rates]. Sven Farm Tidskr; 1966 Jun; 70(18):468-73. PubMed ID: 5968462 [No Abstract] [Full Text] [Related]
17. [Committee for the Study of Adverse Effects of Drugs]. Sven Farm Tidskr; 1966 Feb; 70(6):185-7. PubMed ID: 5961738 [No Abstract] [Full Text] [Related]
18. [Prescribed drug benefits. Reply of the Apothecaries Society]. Sven Farm Tidskr; 1966 Nov; 70(32):761-5. PubMed ID: 5979056 [No Abstract] [Full Text] [Related]
19. [Information for consulting physicians regarding the law on general insurance]. Jochnick CA Lakartidningen; 1966 Aug; 63(31):2878-9. PubMed ID: 5919127 [No Abstract] [Full Text] [Related]
20. [Quality assurance of the basic list of drugs]. Wallén L; von Bahr C Lakartidningen; 1996 Oct; 93(41):3550, 3552. PubMed ID: 8965505 [No Abstract] [Full Text] [Related] [Next] [New Search]